Russia’s Sputnik V coronavirus vaccine to be made in Italy in first EU deal

A Swiss biopharmaceutical company will produce the Sputnik V Covid-19 vaccine at its Italian facilities, marking the first European production agreement for the Russian shot.Lugano, Switzerland-based Adienne Pharma & Biotech SA signed an agreement with Russian sovereign wealth fund RDIF to manufacture the vaccine at its production site in the Milan region, according to a statement on the company’s website.The start of production is subject to approval from Italian regulators with several…

Read the original article at South China Morning Post